134 related articles for article (PubMed ID: 18653594)
1. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-alpha.
Evereklioglu C; Borlu M
Br J Ophthalmol; 2008 Aug; 92(8):1034, 1148-9. PubMed ID: 18653594
[No Abstract] [Full Text] [Related]
2. Author reply: To PMID 24359625.
Read RW; Levy-Clarke G; Jabs DA; Rosenbaum JT; Vitale A; Van Gelder RN
Ophthalmology; 2014 Oct; 121(10):e58-9. PubMed ID: 25015217
[No Abstract] [Full Text] [Related]
3. Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96).
Onal S; Tugal-Tutkun I
Ophthalmology; 2014 Oct; 121(10):e57-8. PubMed ID: 25064722
[No Abstract] [Full Text] [Related]
4. Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
Eser Ozturk H; Oray M; Tugal-Tutkun I
Ocul Immunol Inflamm; 2018; 26(7):1005-1014. PubMed ID: 29020500
[TBL] [Abstract][Full Text] [Related]
5. Early treatment with infliximab in bilateral occlusive vasculitis as a presenting manifestation of Behçet' disease.
Bañeros-Rojas P; Berrozpe-Villabona C; Peraza-Nieves JE; Díaz-Valle D
Arch Soc Esp Oftalmol; 2015 Jun; 90(6):285-8. PubMed ID: 25443189
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
Leclercq M; Le Besnerais M; Langlois V; Girszyn N; Benhamou Y; Ngo C; Levesque H; Muraine M; Gueudry J
Clin Rheumatol; 2018 Mar; 37(3):849-853. PubMed ID: 29397459
[TBL] [Abstract][Full Text] [Related]
7. Behçet disease-associated rhabdomyolysis treated with infliximab.
Hambly TW; Wong NL; Yun J
Intern Med J; 2020 May; 50(5):642-643. PubMed ID: 32431040
[No Abstract] [Full Text] [Related]
8. Duration of anti-TNF treatment in vascular Behçet's disease: better to prolong treatment?
Atas N; Babaoglu H; Varan O; Tufan A
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):147. PubMed ID: 29998843
[No Abstract] [Full Text] [Related]
9. Infliximab-Induced Granulomatous Vasculitis With Amyloid Deposition in the Tongue of a Patient With Behçet Disease.
Iwasaki S; Watanabe T; Tsuji T; Otsuka T; Makita K; Fukasawa Y; Ishizu A
J Clin Rheumatol; 2021 Dec; 27(8S):S710-S712. PubMed ID: 32826655
[No Abstract] [Full Text] [Related]
10. [Not Available].
Kötter I
Dtsch Med Wochenschr; 2017 Oct; 142(20):1535-1539. PubMed ID: 29017212
[TBL] [Abstract][Full Text] [Related]
11. Successful prednisolone treatment of peripartum Behçet disease associated with HLA-A26.
Kiyohara S; Kanemaru H; Suzuki T; Nakamura K; Honda N; Makino K; Kajihara I; Makino T; Ohba T; Ihn H
Australas J Dermatol; 2020 Nov; 61(4):e441-e442. PubMed ID: 32419132
[No Abstract] [Full Text] [Related]
12. [Peripheral arterial circulatory diseases in young adults].
Tatò F
Dtsch Med Wochenschr; 2015 Jun; 140(12):870-3. PubMed ID: 26069908
[No Abstract] [Full Text] [Related]
13. Patient-driven assessment of disease activity in Behçet's syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet's Syndrome Activity Score.
Yilmaz S; Simsek I; Cinar M; Erdem H; Kose O; Yazici Y; Pay S
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):77-83. PubMed ID: 24064020
[TBL] [Abstract][Full Text] [Related]
14. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic events in Fabry disease and the impact of factor V Leiden.
Lenders M; Karabul N; Duning T; Schmitz B; Schelleckes M; Mesters R; Hense HW; Beck M; Brand SM; Brand E
Neurology; 2015 Mar; 84(10):1009-16. PubMed ID: 25663229
[TBL] [Abstract][Full Text] [Related]
16. Behcet disease and pregnancy.
Gungor AN; Kalkan G; Oguz S; Sen B; Ozoguz P; Takci Z; Sacar H; Dogan FB; Cicek D
Clin Exp Obstet Gynecol; 2014; 41(6):617-9. PubMed ID: 25551950
[TBL] [Abstract][Full Text] [Related]
17. Value of certain echocardiographic findings in the initial suspicion of Behçet's disease.
Farouk H; Chilali KE; Said K; Sakr B; Salah H; Mahmoud G; Sorour K
Echocardiography; 2014 Sep; 31(8):924-30. PubMed ID: 25208862
[TBL] [Abstract][Full Text] [Related]
18. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease.
Ishikawa S; Taguchi M; Muraoka T; Sakurai Y; Kanda T; Takeuchi M
Br J Ophthalmol; 2014 Nov; 98(11):1508-13. PubMed ID: 24939422
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.
San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR
Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality-of-life and treatment targets in myasthenia gravis.
Utsugisawa K; Suzuki S; Nagane Y; Masuda M; Murai H; Imai T; Tsuda E; Konno S; Nakane S; Suzuki Y; Fujihara K; Suzuki N
Muscle Nerve; 2014 Oct; 50(4):493-500. PubMed ID: 24536040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
